AAAAAA

   
Results: 1-23 |
Results: 23
NOVEL M1 MUSCARINIC AGONISTS IN TREATMENT AND DELAYING THE PROGRESSION OF ALZHEIMERS-DISEASE - AN UNIFYING HYPOTHESIS
Authors: FISHER A BRANDEIS R HARING R ESHHAR N HELDMAN E KARTON Y EISENBERG O MESHULAM H MARCIANO D BARNER N PITTEL Z
Citation: A. Fisher et al., NOVEL M1 MUSCARINIC AGONISTS IN TREATMENT AND DELAYING THE PROGRESSION OF ALZHEIMERS-DISEASE - AN UNIFYING HYPOTHESIS, J PHYSL-PAR, 92(5-6), 1998, pp. 337-340
EXPRESSION AND LOCALIZATION OF MUSCARINIC RECEPTORS IN P19-DERIVED NEURONS
Authors: PARNAS D HELDMAN E BRANSKI L FEINSTEIN N LINIAL M
Citation: D. Parnas et al., EXPRESSION AND LOCALIZATION OF MUSCARINIC RECEPTORS IN P19-DERIVED NEURONS, Journal of molecular neuroscience, 10(1), 1998, pp. 17-29
REGULATION OF ADENYLYL-CYCLASE ISOZYMES ON ACUTE AND CHRONIC ACTIVATION OF INHIBITORY RECEPTORS
Authors: NEVO I AVIDORREISS T LEVY R BAYEWITCH M HELDMAN E VOGEL Z
Citation: I. Nevo et al., REGULATION OF ADENYLYL-CYCLASE ISOZYMES ON ACUTE AND CHRONIC ACTIVATION OF INHIBITORY RECEPTORS, Molecular pharmacology, 54(2), 1998, pp. 419-426
MITOGEN-ACTIVATED PROTEIN KINASE-DEPENDENT AND PROTEIN-KINASE C-DEPENDENT PATHWAYS LINK THE M1 MUSCARINIC RECEPTOR TO BETA-AMYLOID PRECURSOR PROTEIN SECRETION
Authors: HARING R FISHER A MARCIANO D PITTEL Z KLOOG Y ZUCKERMAN A ESHHAR N HELDMAN E
Citation: R. Haring et al., MITOGEN-ACTIVATED PROTEIN KINASE-DEPENDENT AND PROTEIN-KINASE C-DEPENDENT PATHWAYS LINK THE M1 MUSCARINIC RECEPTOR TO BETA-AMYLOID PRECURSOR PROTEIN SECRETION, Journal of neurochemistry, 71(5), 1998, pp. 2094-2103
THE INTERACTION OF LIPOPHILIC QUATERNARY CARBAMATES WITH M1 AND M2 MUSCARINIC RECEPTORS
Authors: AMITAI G ADANI R SODMORIAH G RACHMAN E HELDMAN E
Citation: G. Amitai et al., THE INTERACTION OF LIPOPHILIC QUATERNARY CARBAMATES WITH M1 AND M2 MUSCARINIC RECEPTORS, Neuroscience letters, 1997, pp. 3-3
AN M1 SELECTIVE AGONIST AF102B, AS A POTENTIAL-DRUG IN TREATMENT OF ALZHEIMERS-DISEASE - BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES
Authors: HARING R ESHHAR N HELDMAN E MARCIANO D KLOOG Y FISHER A
Citation: R. Haring et al., AN M1 SELECTIVE AGONIST AF102B, AS A POTENTIAL-DRUG IN TREATMENT OF ALZHEIMERS-DISEASE - BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES, Life sciences, 60(13-14), 1997, pp. 43-43
CORRELATION BETWEEN SECRETAGOGUE-INDUCED CA2+ INFLUX, INTRACELLULAR CA2+ LEVELS AND SECRETION OF CATECHOLAMINES IN CULTURED ADRENAL CHROMAFFIN CELLS
Authors: HELDMAN E BARG J VOGEL Z POLLARD HB ZIMLICHMAN R
Citation: E. Heldman et al., CORRELATION BETWEEN SECRETAGOGUE-INDUCED CA2+ INFLUX, INTRACELLULAR CA2+ LEVELS AND SECRETION OF CATECHOLAMINES IN CULTURED ADRENAL CHROMAFFIN CELLS, Neurochemistry international, 28(3), 1996, pp. 325-334
DEHYDROEPIANDROSTERONE (DHEA) INCREASES PRODUCTION AND RELEASE OF ALZHEIMERS AMYLOID PRECURSOR PROTEIN
Authors: DANENBERG HD HARING R FISHER A PITTEL Z GURWITZ D HELDMAN E
Citation: Hd. Danenberg et al., DEHYDROEPIANDROSTERONE (DHEA) INCREASES PRODUCTION AND RELEASE OF ALZHEIMERS AMYLOID PRECURSOR PROTEIN, Life sciences, 59(19), 1996, pp. 1651-1657
NOVEL M1 AGONISTS - FROM SYMPTOMATIC TREATMENT TO DELAYING THE PROGRESSION OF ALZHEIMERS-DISEASE (AD)
Authors: FISHER A HARING R GINZBURG I SADOT E PITTEL Z BARG Y BEHAR L GURWITZ D KARTON Y MESHULAM H MARCIANO D BRANDEIS R HELDMAN E
Citation: A. Fisher et al., NOVEL M1 AGONISTS - FROM SYMPTOMATIC TREATMENT TO DELAYING THE PROGRESSION OF ALZHEIMERS-DISEASE (AD), Journal of neurochemistry, 66, 1996, pp. 9-9
TRANSDUCTION PATHWAYS MEDIATING MUSCARINIC-STIMULATED AMYLOID PRECURSOR PROTEINS (APPS) SECRETION AND CELL-DIFFERENTIATION
Authors: HARING R HELDMAN E PITTEL Z KLOOG Y MARCIANO D ZUCKERMAN A DANENBERG H KUSHNIR M FISHER A
Citation: R. Haring et al., TRANSDUCTION PATHWAYS MEDIATING MUSCARINIC-STIMULATED AMYLOID PRECURSOR PROTEINS (APPS) SECRETION AND CELL-DIFFERENTIATION, Journal of neurochemistry, 66, 1996, pp. 12-12
CELL MODELS FOR THE STUDY OF OPIATE DRUG-ADDICTION
Authors: NEVO I AVIDORREISS T HELDMAN E LEVY R SAYA D MATUSLEIBOVITCH N BAYEWITCH M RHEE MH VOGEL Z
Citation: I. Nevo et al., CELL MODELS FOR THE STUDY OF OPIATE DRUG-ADDICTION, Journal of neurochemistry, 66, 1996, pp. 61-61
PHARMACOLOGICAL BASIS FOR FUNCTIONAL SELECTIVITY OF PARTIAL MUSCARINIC RECEPTOR AGONISTS
Authors: HELDMAN E BARG J FISHER A LEVY R PITTEL Z ZIMLICHMAN R KUSHNIR M VOGEL Z
Citation: E. Heldman et al., PHARMACOLOGICAL BASIS FOR FUNCTIONAL SELECTIVITY OF PARTIAL MUSCARINIC RECEPTOR AGONISTS, European journal of pharmacology, 297(3), 1996, pp. 283-291
MUSCARINIC CONTROL OF AMYLOID PRECURSOR PROTEIN SECRETION IN RAT CEREBRAL-CORTEX AND CEREBELLUM
Authors: PITTEL Z HELDMAN E BARG J HARING R FISHER A
Citation: Z. Pittel et al., MUSCARINIC CONTROL OF AMYLOID PRECURSOR PROTEIN SECRETION IN RAT CEREBRAL-CORTEX AND CEREBELLUM, Brain research, 742(1-2), 1996, pp. 299-304
NGF-DEPENDENT NEUROTROPHIC-LIKE EFFECTS OF AF102B, AN M1 MUSCARINIC AGONIST, IN PC12M1 CELLS
Authors: GURWITZ D HARING R PINKASKRAMARSKI R STEIN R HELDMAN E KARTON Y FISHER A
Citation: D. Gurwitz et al., NGF-DEPENDENT NEUROTROPHIC-LIKE EFFECTS OF AF102B, AN M1 MUSCARINIC AGONIST, IN PC12M1 CELLS, NeuroReport, 6(3), 1995, pp. 485-488
LOW-DOSES OF ANANDAMIDES INHIBIT PHARMACOLOGICAL EFFECTS OF DELTA(9)-TETRAHYDROCANNABINOL
Authors: FRIDE E BARG J LEVY R SAYA D HELDMAN E MECHOULAM R VOGEL Z
Citation: E. Fride et al., LOW-DOSES OF ANANDAMIDES INHIBIT PHARMACOLOGICAL EFFECTS OF DELTA(9)-TETRAHYDROCANNABINOL, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 699-707
CANNABINOMIMETIC BEHAVIORAL-EFFECTS OF AND ADENYLATE-CYCLASE INHIBITION BY 2 NEW ENDOGENOUS ANANDAMIDES
Authors: BARG J FRIDE E HANUS L LEVY R MATUSLEIBOVITCH N HELDMAN E BAYEWITCH M MECHOULAM R VOGEL Z
Citation: J. Barg et al., CANNABINOMIMETIC BEHAVIORAL-EFFECTS OF AND ADENYLATE-CYCLASE INHIBITION BY 2 NEW ENDOGENOUS ANANDAMIDES, European journal of pharmacology, 287(2), 1995, pp. 145-152
NGF PROMOTES AMYLOID PRECURSOR PROTEIN SECRETION VIA MUSCARINIC RECEPTOR ACTIVATION
Authors: HARING R GURWITZ D BARG J PINKASKRAMARSKI R HELDMAN E PITTEL Z DANENBERG HD WENGIER A MESHULAM H MARCIANO D KARTON Y FISHER A
Citation: R. Haring et al., NGF PROMOTES AMYLOID PRECURSOR PROTEIN SECRETION VIA MUSCARINIC RECEPTOR ACTIVATION, Biochemical and biophysical research communications, 213(1), 1995, pp. 15-23
DISCRETE ACTIVATION OF TRANSDUCTION PATHWAYS ASSOCIATED WITH ACETYLCHOLINE-M1 RECEPTOR BY SEVERAL MUSCARINIC LIGANDS
Authors: GURWITZ D HARING R HELDMAN E FRASER CM MANOR D FISHER A
Citation: D. Gurwitz et al., DISCRETE ACTIVATION OF TRANSDUCTION PATHWAYS ASSOCIATED WITH ACETYLCHOLINE-M1 RECEPTOR BY SEVERAL MUSCARINIC LIGANDS, European journal of pharmacology. Molecular pharmacology section, 267(1), 1994, pp. 21-31
ANTINEURALGIC EFFECT OF PYRIDOSTIGMINE
Authors: KUSHNIR M HELDMAN E
Citation: M. Kushnir et E. Heldman, ANTINEURALGIC EFFECT OF PYRIDOSTIGMINE, Neurology, 44(4), 1994, pp. 10000344-10000344
NGF PROMOTES M1 MUSCARINIC RECEPTOR-STIMULATED AMYLOID PRECURSOR PROTEIN SECRETION IN PC12 CELLS
Authors: HARING R GURWITZ D BARG Y PINKASKRAMARSKI R HELDMAN E PITTEL Z WENGIER A KARTON I FISHER A
Citation: R. Haring et al., NGF PROMOTES M1 MUSCARINIC RECEPTOR-STIMULATED AMYLOID PRECURSOR PROTEIN SECRETION IN PC12 CELLS, Journal of neurochemistry, 63, 1994, pp. 190000071-190000071
AGONIST-STIMULATED RELEASE OF VON-WILLEBRAND-FACTOR AND PROCOAGULANT FACTOR-VIII IN RATS WITH AND WITHOUT RISK-FACTORS FOR STROKE
Authors: MCCARRON RM DORON DA SIREN AL FEUERSTEIN G HELDMAN E POLLARD HB SPATZ M HALLENBECK JM
Citation: Rm. Mccarron et al., AGONIST-STIMULATED RELEASE OF VON-WILLEBRAND-FACTOR AND PROCOAGULANT FACTOR-VIII IN RATS WITH AND WITHOUT RISK-FACTORS FOR STROKE, Brain research, 647(2), 1994, pp. 265-272
AMYLOID PRECURSOR PROTEIN SECRETION VIA MUSCARINIC RECEPTORS - REDUCED DESENSITIZATION USING THE M1-SELECTIVE AGONIST AF102B
Authors: HARING R GURWITZ D BARG J PINKASKRAMARSKI R HELDMAN E PITTEL Z WENGIER A MESHULAM H MARCIANO D KARTON Y FISHER A
Citation: R. Haring et al., AMYLOID PRECURSOR PROTEIN SECRETION VIA MUSCARINIC RECEPTORS - REDUCED DESENSITIZATION USING THE M1-SELECTIVE AGONIST AF102B, Biochemical and biophysical research communications, 203(1), 1994, pp. 652-658
ANANDAMIDE, A BRAIN ENDOGENOUS COMPOUND, INTERACTS SPECIFICALLY WITH CANNABINOID RECEPTORS AND INHIBITS ADENYLATE-CYCLASE
Authors: VOGEL Z BARG J LEVY R SAYA D HELDMAN E MECHOULAM R
Citation: Z. Vogel et al., ANANDAMIDE, A BRAIN ENDOGENOUS COMPOUND, INTERACTS SPECIFICALLY WITH CANNABINOID RECEPTORS AND INHIBITS ADENYLATE-CYCLASE, Journal of neurochemistry, 61(1), 1993, pp. 352-355
Risultati: 1-23 |